is a highly educated, high-value corporate entity that promotes diversity, ingenuity and innovation in the field of ophthalmology. Euvision's mission is to conceptualize, develop and commercialize medical technologies in the field of vision, promoting the care and well-being of the same. Ideally, the Euvison arsenal includes accurate screening equipment that is used to assess the risk of amblyopia
, a common childhood abnormality responsible for the majority of vision loss among people under the age of forty. Originally, the Euvision team evolved from varied areas of academic research and was formed from a group of young scientists engaged in binocular vision research at the University of Pécs Faculty of Medicine . Euvision's goal is twofold, enriching your business acumen and enhancing eye exams while pursuing academic achievement, including basic and clinical research, publication in scientific journals, and medical conferences. In early 2021, Euvision will launch a breakthrough in child vision screening, designated EuvisionTab ©, which is a mobile-device-based exam application designed for pediatric vision professionals, such as optometrists and ophthalmologists. EuvisionTab © is a compact, easy-to-use and cost-effective solution for mass screening for amblyopia and amblyogenic childhood eye conditions. EuvisionTab © integrates a dynamic / static stereo vision test and a visual acuity test module in a single medical device.
